A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
Active, not recruiting · NCT07246941 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Active, not recruiting | Phase 1 | 2026-09-02 | NCT07246941 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge Centre for Brain Repair | Cambridge | United Kingdom | 1 |
| Hospital Britanico de Buenos Aires | Ciudad Autonoma Bs As | Argentina | 1 |
| Monash Health | Clayton | Australia | 74 |
| Montreal Neurological Institute Clinical Research Unit | Montral | Canada | 1 |
| New Zealand Brain Research Institute | Christchurch | New Zealand | 4 |
| Royal Melbourne Hospital | Parkville | Australia | 39 |
| Westmead Hospital | Westmead | Australia | 128 |